Skyline Medical Signs Agreement for GLG Pharma to be Exclusive Distributor of STREAMWAY System in the U.K.

MINNEAPOLIS, Nov. 01, 2016  -- Skyline Medical Inc. (SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing of a distribution agreement granting GLG Pharma, LLC (“GLG”) exclusive rights to market and distribute the STREAMWAY® System in the U.K.
 
Under the terms of the agreement, GLG will be responsible for all sales and marketing activities, including hiring and training the appropriate number of direct sales representatives to cover the 3,600 operating rooms in the U.K.  Marketing is expected to begin immediately upon receipt of the CE Mark.  Skyline applied for CE Mark approval to market STREAMWAY in the European Union and certain other countries in July 2016, following receipt of ISO 13485:2003 certification.  
Published: 01 November 2016
Written by Editor
Nasdaq   New Product or Order   Up on News  
Read more: Skyline Medical Inc ( SKLN )

Healthways Reports Second-Quarter 2016 Financial Results

NASHVILLE, Tenn., Aug. 09, 2016 -- Healthways (HWAY) today announced financial results for the second quarter and six months ended June 30, 2016. 
 
Second-Quarter 2016 Financial Highlights  
Revenue growth from continuing operations (Network Solutions business) of 10.2% to $125.0 million from $113.4 million for the second quarter of 2015;
Net income from continuing operations of $20.0 million, or $0.54 per diluted share, compared with $10.8 million, or $0.29 per diluted share, for the second quarter of 2015. Net income for the second quarter of 2016 reflected an effective income tax rate of 0.0% as a result of tax benefits from the loss from discontinued operations for the second quarter of 2016, discussed below. For comparison, had the net income for the second quarter of 2016 been subject to a normalized tax rate of 40%, net income from continuing operations would have been $12.0 million or $0.32 per diluted share; and
Losses from discontinued operations, net of income tax expense, of $195.5 million, or $5.25 per diluted share, primarily due to the second-quarter operating loss incurred by the Total Population Health Services and Emerging Solutions businesses and the Company’s estimate of the impairment loss resulting from the classification of the assets of these businesses as held for sale.
Published: 10 August 2016
Written by Editor
Nasdaq   Financial Results   Up on News  
Read more: Healthways ( HWAY )

Sharecare Acquires Healthways’ Population Health Business, Secures Leadership Position in Employer and Health Plan Markets

ATLANTA, July 27, 2016 -- Sharecare, the digital health company helping people manage all their healthcare in one place, today announced it is acquiring the Population Health business of Healthways (HWAY), including:Gallup-Healthways Well-Being Index®; Innergy Healthier Weight, a collaboration with Johns Hopkins Medicine that provides a high-touch, personalized solution proven to sustain weight loss; its two Emerging Solutions businesses, Dan Buettner’s Blue Zones Project® and Dr. Ornish’s Program for Reversing Heart Disease™; and Healthways’ stake in Healthways Brasil Servicos de Consultoria Ltda., its Brazil-based joint venture and innovation lab with SulAmerica Servicos de Saude S.A., a subsidiary of the largest independent insurer in Brazil, Sul America S.A. (BM&FBovespa:SULA11).
Published: 28 July 2016
Written by Editor
Nasdaq   Up on News  
Read more: Healthways ( HWAY )

Nobilis Health Corp. Releases Strong Third Quarter 2015 Results, Completes Previously Announced Financial Restatement

HOUSTON, TX--(January 12, 2016) - Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis" or the "Company") today announced its third quarter financial results and that it has filed all restated financial results arising from the restatement announced on January 5, 2016 and detailed in the Form 8-K (Item 4.02) filed on January 5, 2016 (collectively, the "Restatement Reports"). 

Detailed information relating to the financial results for the three and nine months ended September 30, 2015 is available in our Form 10-Q filed today with the Securities and Exchange Commission and applicable Canadian securities regulators, which can be accessed on our web site www.NobilisHealth.com, www.SEC.gov, and www.Sedar.com.

Published: 13 January 2016
Written by Editor
Nasdaq   Financial Results   Up on News  
Read more: Nobilis Health Corp ( HLTH / NHC )

Patient Home Monitoring Posts Record Audited Year-end Financials; Releases Record First Quarter Revenue and Profit Figures

LAFAYETTE, LOUISIANA--(Marketwired - Jan 4, 2016) - Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on the annuity-based healthcare services market in the US announced that it posted Audited financials for the year ended September 30, 2015. Along with the full year results, PHM released revenue and profit figures for the quarter ending December 31, 2015.

PHM is offering an ever-larger suite of products and services to an increased geographic footprint in the US. While investing in enrollment growth for all of its existing products and services, PHM's mission in the market has always been to offer newly reimbursed and high demand services and products to patients. These cutting edge products often offer higher margins and limited competition.

Published: 04 January 2016
Written by Editor
Financial Results   Up on News   TSXV  
Read more: Patient Home Monitoring ( PHM )
  1. iKang Healthcare Group Inc ( KANG )
  2. Liberator Medical Holdings Inc ( LBMH )
  3. Advanced Accelerator Applications ( AAAP )
  4. Abaxis Inc ( ABAX )
  5. Nobilis Health Corp ( NHC / HLTH )

Subcategories

Pharmaceuticals

Medical Laboratories & Research